SEC Form 4 research
| Issuer | GLYCOMIMETICS INC |
|---|---|
| Tickers | GLYC, CBIO |
| Reporting owners | 73 |
| Officers and directors | 24 |
| Last public filing | 2026-09-18 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-18 | 2026-09-16 | Lynch Ryan | S | 240 | $17.9 | Not reported |
| 2026-09-18 | 2026-09-16 | Pinkas Jan | S | 658 | $17.9 | Not reported |
| 2026-09-18 | 2026-09-16 | Im Ellie Eunkyung | S | 623 | $17.9 | Not reported |
| 2026-09-18 | 2026-09-16 | Scalzo Richard William | S | 568 | $17.9 | Not reported |
| 2026-09-18 | 2026-09-16 | Bispham Barbara Harlin | S | 620 | $17.9 | Not reported |
| 2026-09-18 | 2026-09-18 | Brumm Joshua T | S | 7,837 | $16.71 | Not reported |
| 2026-09-18 | 2026-09-16 | Brumm Joshua T | S | 1,610 | $17.9 | Not reported |
| 2026-09-18 | 2026-09-18 | McNeill Jonathan | S | 3,839 | $16.71 | Not reported |
| 2026-09-18 | 2026-09-16 | McNeill Jonathan | S | 731 | $17.9 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.